Item Type | Name |
Concept
|
Double-Blind Method
|
Academic Article
|
Effect of morning versus evening dosing of diltiazem on myocardial ischemia detected by ambulatory electrocardiographic monitoring in chronic stable angina pectoris. Dilacor XR Ambulatory Ischemia Study Group.
|
Academic Article
|
Comparison of effects of nisoldipine-extended release and amlodipine in patients with systemic hypertension and chronic stable angina pectoris.
|
Academic Article
|
Sildenafil citrate does not reduce exercise tolerance in men with erectile dysfunction and chronic stable angina.
|
Academic Article
|
Comparison of five beta-adrenoreceptor antagonists with different ancillary properties during sustained twice daily therapy in angina pectoris.
|
Academic Article
|
Amlodipine in chronic stable angina: results of a multicenter double-blind crossover trial.
|
Academic Article
|
Usefulness of clinical information to distinguish patients with normal from those with low ejection fractions in heart failure.
|
Academic Article
|
Effects of angiotensin-converting enzyme inhibition on transient ischemia: the Quinapril Anti-Ischemia and Symptoms of Angina Reduction (QUASAR) trial.
|
Academic Article
|
Long-term follow-up of participants with heart failure in the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT).
|
Academic Article
|
Effects of 8:00 a.m. and 2:00 p.m. doses of isosorbide-5-mononitrate during twice-daily therapy in stable angina pectoris.
|
Academic Article
|
Transdermal nitroglycerin patches in angina pectoris. Dose titration, duration of effect, and rapid tolerance.
|
Academic Article
|
The effectiveness of transcutaneous nitrate preparations for angina pectoris.
|
Academic Article
|
Duration of effects of isradipine during twice daily therapy in angina pectoris.
|
Academic Article
|
Dose-response evaluation of once-daily therapy with a new formulation of diltiazem for stable angina pectoris. Diltiazem CD Study Group.
|
Academic Article
|
Double-blind efficacy and safety study of a novel anti-ischemic agent, ranolazine, versus placebo in patients with chronic stable angina pectoris. Ranolazine Study Group.
|
Academic Article
|
Effects of treatment on outcome in mildly symptomatic patients with ischemia during daily life. The Atenolol Silent Ischemia Study (ASIST)
|
Academic Article
|
Lack of pharmacologic tolerance and rebound angina pectoris during twice-daily therapy with isosorbide-5-mononitrate.
|
Academic Article
|
Double-blind, dose-response, placebo-controlled multicenter study of nisoldipine. A new second-generation calcium channel blocker in angina pectoris.
|
Academic Article
|
Efficacy and safety of fasudil in patients with stable angina: a double-blind, placebo-controlled, phase 2 trial.
|
Academic Article
|
A multicenter comparison of isradipine and prazosin for treatment of essential hypertension.
|
Academic Article
|
Long-term bepridil monotherapy for angina pectoris.
|
Academic Article
|
Isosorbide-5-mononitrate in angina pectoris: plasma concentrations and duration of effects after acute therapy.
|
Academic Article
|
Usefulness of twice-daily isosorbide-5-mononitrate in preventing development of tolerance in angina pectoris.
|
Academic Article
|
Propranolol in angina pectoris: comparison of therapy given two and four times daily.
|
Academic Article
|
Additional antianginal and anti-ischemic efficacy of mibefradil in patients pretreated with a beta blocker for chronic stable angina pectoris.
|
Academic Article
|
Evaluation of a weight-adjusted single-bolus plasminogen activator in patients with myocardial infarction: a double-blind, randomized angiographic trial of lanoteplase versus alteplase.
|
Academic Article
|
The effect of vardenafil, a potent and highly selective phosphodiesterase-5 inhibitor for the treatment of erectile dysfunction, on the cardiovascular response to exercise in patients with coronary artery disease.
|
Academic Article
|
Clinical outcomes in antihypertensive treatment of type 2 diabetes, impaired fasting glucose concentration, and normoglycemia: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
|
Academic Article
|
Effects of glucose-insulin-potassium infusion on the angina response during treadmill exercise.
|
Academic Article
|
Duration of effects and tolerance of slow-release isosorbide-5-mononitrate for angina pectoris.
|
Academic Article
|
Comparative efficacy of 200, 300 and 400 mg of bepridil for chronic stable angina pectoris.
|
Academic Article
|
Effects of zatebradine (ULFS 49 CL), a sinus node inhibitor, on heart rate and exercise duration in chronic stable angina pectoris. Zatebradine Investigators.
|
Academic Article
|
Effect of Obesity on Response to Spironolactone in Patients With Heart Failure With Preserved Ejection Fraction.
|